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For the past three decades myocardial perfusion
imaging SPECT (MPI-SPECT) has managed to prevail
as one of the most important non-invasive imaging
techniques in cardiology. The strengths of MPI-SPECT
include the reliance on physiology rather than anatom-
ical features of the coronary circulation, its standardized
and efficient methodology, and a large body of evidence
supporting its clinical value. However, while taking
advantage of all these benefits inherent to the method,
we have for long time neglected the need to push on
technical developments and innovations and it may
seem as if MPI-SPECT has missed the step into the
twenty-first century. In fact, almost all around the globe,
MPI-SPECT is still performed in a similar manner to 20
or 30 years ago using essentially the same radionuclides,
protocols, and camera designs. In an era of emerging
technologies and multimodality imaging, MP-SPECT
has to compete with other techniques that are faster or
avoid ionizing radiation such as CT coronary angiog-
raphy or cardiac magnetic resonance. Thus, a technique
which requires 20- to 30-minute acquisition time and
exposes the patient to 10-25 mSv of ionizing radiation
appears to be an endangered species in the cardiac
imaging field.
However, recent years have witnessed important
developments in device technology and a number of
novel camera designs for dedicated cardiac MPI-SPECT
have entered commercial production.1 Solid-state
semiconductor detectors made of a cadmium-zinc-tel-
luride (CZT) alloy provide direct conversion of absorbed
gamma-rays into an electrical signal and avoid the need
for the bulky photomultiplier tubes used in conventional
SPECT cameras. In 2008, GE Healthcare has introduced
a CZT-based dedicated cardiac scanner (Discovery NM
530c) to the market. This device consists of 19 fixed
arrays of pixilated CZT detectors assembled into a
unique geometry that allows obtaining simultaneous
views of the heart from different angles. This design
coupled with the use of a proprietary multi-pinhole
collimator improves count sensitivity compared to con-
ventional devices while the CZT detector technology
provides higher energy and spatial resolution. Indeed
phantom studies have demonstrated improvements of 5-
7-fold in count sensitivity, 1.7-2.5-fold in spatial reso-
lution, and 1.65-fold in energy resolution. Similar
technology has been introduced by other vendors.2
In nuclear cardiology image quality is determined to
a large extent by high count statistics, which are based
on a trade-off between injected radiotracer activity and
duration of image acquisition. Thus, it can be anticipated
that protocols consisting of lower radionuclide doses and
shorter acquisition times would push the boundaries of
image quality in conventional scanners. With higher
sensitivity SPECT devices such as the Discovery NM
530c, incentives to reduce acquisition times rather than
radiation exposure to the patient were higher given the
prospect for improved efficiency and patient throughput.
Hence, a number of reports have been published dem-
onstrating high image quality with CZT devices and
comparable diagnostic performance with acquisition
times as short as 2 minutes.3,4 However, the potential
risks and hazards from ionizing radiation have obtained
increasing public attention given to exponential growth
of radiation exposure from medical imaging in the past
years. And the recent devastating nuclear accidents with
emission of unknown amounts of radionuclides into the
environment have further sensitized the public to this
issue. Therefore, nuclear cardiologists have been urged
to reduce patients’ radiation exposure from MPI-
SPECT, if ever possible without increasing acquisition
times and thereby reducing patient comfort. Some
diagnostic centers have implemented stress-only MP-
SPECT protocols, thereby avoiding unnecessary rest
studies in the presence of normal stress studies, which
may reduce radiation exposure in a subgroup of patients.
However, this approach requires an optimal set-up with
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nuclear physicians interpreting images immediately
after scanning, and may pose logistic problems in cen-
ters that perform central reading at the end of the day.
Positron emission tomography with either radiolabeled
15O-water or 13N-ammonia is an excellent alternative to
MPI-SPECT with a lower radiation exposure. However,
availability is poor as these tracers are cyclotron-
dependent and their short physical half-lives render
dissemination and use in PET centers without on-site
cyclotron impossible.
In the present issue of the Journal of Nuclear
Cardiology, Duvall et al5 make an important step for-
ward in low-dose MPI-SPECT. In 131 consecutive
patients, they assessed the feasibility of MPI with a
reduced isotope dose (5-mCi rest and 15-mCi stress) and
imaging time (5-minute rest and 3-minute stress) com-
pared to a protocol with the same doses but longer
acquisition times (8 and 5 minutes) on a Discovery NM
530c CZT scanner. A subgroup of 27 patients underwent
stress imaging on a conventional dual-head SPECT
camera. There were no significant differences in image
quality, summed perfusion scores, and inter- or intra-
observer variability between short and long acquisition
times. Similarly, when stress images were compared
between CZT SPECT and conventional SPECT, total
perfusion deficits were comparable while image quality
was even superior with CZT SPECT. The effective dose
for a whole study was 5.8 mSv which is half the dose
from a conventional full-dose one day rest/stress pro-
tocol with 99mTc-tracers.
The ability of the CZT device to obtain high image
quality at low doses is explained by its high count
sensitivity based on the above-mentioned geometric
alignment of CZT detectors, which allows simultaneous
acquisition of all required views. The potential loss of
image resolution with multipinhole collimation com-
pared to parallel-hole collimation is compensated by the
higher energy resolution of the CZT detector (in the
range of 5.7% compared to 9.4% with sodium iodide
detectors) which can reduce the scatter component of
total counts by 30%. Indeed, in the present report by
Duvall and colleagues, total count rates were double as
high with the CZT device compared to conventional
SPECT. Although this underlines the higher sensitivity
of the CZT device, the numbers are lower than reported
from phantom studies. A previous study documented a
7.22-fold increase in count rate sensitivity for a point
source, a 6.34-fold, increase using a cardiac phantom,
and a 4.1-7.0-fold increase for clinical perfusion stud-
ies.1 However, the comparison of the small field-of-view
CZT camera with a conventional dual-head camera
should be interpreted with caution as count rates are
likely to be overestimated by the large field-of-view
device due to greater contribution from extracardiac
activity. This is further supported by the slightly higher
image quality in the CZT images reported by Duvall and
colleagues. Additionally, left ventricular ejection frac-
tion and volumes from the CZT device correlated well
with conventional gated SPECT. This represents further
evidence of a comparable performance of the low-dose
short acquisition time protocol as gated SPECT is par-
ticularly prone to artefacts with low count statistics.
The ability to reduce the effective dose of a full rest/
stress gated MPI-SPECT study represents a major step
forward in nuclear cardiology and is crucial to maintain
MPI-SPECT competitive in the cardiac imaging arena.
This study provides the first proof that the concept of
reducing injected dose while at the same time shortening
image acquisition protocols in MP-SPECT is feasible
and reproducible and provides high-quality images.
However, it should be noted that the present manuscript
consisted of a comparison with a reduced-dose protocol
with longer acquisition times (8 and 5 minutes, respec-
tively) whereas only a subgroup was compared to the
established conventional method. Therefore, further
studies in larger cohorts comparing image quality and
perfusion information to conventional dual-head scan-
ners and direct comparisons to the gold standard
invasive coronary angiography are needed to consolidate
the clinical usefulness of this novel approach. The
reduction of radiation exposure and duration of image
acquisition is a long-awaited step forward in nuclear
cardiology, and it seems that the technology to reach this
goal is finally in our hands. Thanks to these achieve-
ments, nuclear cardiology will remain to play a vital role
in the assessment of patients with coronary artery dis-
ease alongside with newer methods such as CT and
cardiac magnetic resonance. Additionally, with lower
radiation burden, MPI-SPECT will become a more
attractive modality for incorporation into multimodality
or hybrid imaging systems.6 With these perspectives at
hand, it truly appears as if conventional nuclear cardi-
ology has finally taken the step into the new century and
embarked into a new era of MPI-SPECT.
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